To further expand the application range of our prediction model, the individualized prediction model for OS prediction based on predictive factors, including recurrent score, primary/recurrent status, histology, age, postoperative radiotherapy, and IDH mutation status was also established for (1‐,2‐, 3‐,5‐ and 10‐year) survival probability prediction of low‐grade glioma patients (Figure S2A). This evidence concerns the gene IDH1 and central nervous system cancer.